Abstract
Abstract
Two unrelated female infants with homozygous protein C (Pr C) deficiency are reported. Both are of U.K. Pakistani origin and in each case the parents are consanguinous. A previous sibling had died in each family. Both sets of parents were shown to be carriers. The concentration of Pr C in both infants was low at birth. Both developed necrotic skin lesions (purpura fulminans) and responded well to Pr C concentrate. Both are developing normally although one has visual impairment due to retinal artery thrombosis which occurred before treatment was commenced. Both infants are treated with intravenous Pr C concentrate administerd daily by the parents at home. Studies of the half-life of exogenous Pr C in one of the patients has shown an increase from 2.7 to 10.8 h during the course of treatment thus enabling it to be administered once daily while still maintaining effective plasma concentrations. In the other patient half-life has fluctuated but Pr C is also given once daily. This is the first report of this condition being treated in this way in the United Kingdom.
Conclusion
Infusion of Pr C is a safe and efficient way of treating infants with homozygous Pr C deficiency in the medium term.
Similar content being viewed by others
Abbreviations
- FFP :
-
fresh frozen plasma
- PCC :
-
prothrombin complex concentrate
- Pr C :
-
protein C
- Pr C(a) :
-
antigenic Protein C
- Pr C(f) :
-
functional (ie bioactive) Protein C
References
Autetta MJ, Headington JT (1988) Purpura fulminans: a cutaneous manifestation of severe Protein C deficiency. Arch Dermatol 124: 1387–1391
Casella JF, Bontempo FA, Markel H, Lewis JH, Zitelli BJ, Starzl TE (1988) Successful treatment of homozygous protein C deficiency by hepatic transplantation. Lancet 8583(I): 435–437
Dreyfus M, Magny JF, Bridey F, Schwarz HP, Planche C, Dehan M, Tchemia G (1991) Treatment of homozygous Protein C deficiency and neonatal purpura fulminans with a purified Protein C concentrate. N Engl J Med 325: 1565–1568
Hartman KR, Manco-Johnson M, Rawlings JS, Bower DJ, Marlar RA (1989) Homozygous protein C deficiency: early treatment with warfarin. Am J Pediatr Hematol Oncol 11: 395–401
Hermsen VM, Conahan JB, Koops BL, Cunningham RD (1990) Persistent hyperplastic primary vitreous associated with Protein C deficiency. Am J Ophthalmol 109: 608–609
Mannucci PM, Schimpf K, Abe T, Aledort LM, Anderle K, Brettler DB, Hilgartner MW, Kernoff PB, Kunschak M, McMillan CW, et al (1992) Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group. Transfusion 32: 134–138
Marlar RA, Montgomery RR, Broekmans AW, Working Party (1989) Diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party of the Subcommittee on Protein C and Protein S, International Committee on Thrombosis and hemostasis. J Pediatr 114: 528–553
Marlar RA, Montgomery RR, Broekmans AW (1989) Diagnosis and treatment of homozygous Protein C deficiency. J Pediatr 114: 528–534
Masterson M, Schwarz H-P, Coutinho M, Glueck H, Gruppo R, Lamkin BC (1991) Use of purified protein C concentrate for treatment of protein C deficiency in infancy. Scientific Proceedings of the American Society of Pediatric Hematology/Oncology, 4th Annual Meeting, Chicago, p17
Miletech J, Sherman L, Broze G (1987) Absence of thrombosis in subjects with heterozygous Protein C deficiency. N Engl J Med 317: 991–996
Peters C, Casella JF, Marlar RA, Montgomery RR, Zinkham WH (1988) Homozygous protein C deficiency; observations on the nature of the molecular abnormality and the effectiveness of warfarin therapy. Pediatrics 81: 272–276
Preiss DU, Eberspacher B, Abdullah D, Rosner I (1991) Safety of vapour heated prothrombin complex concentrate (PCC) Prothrombplex S-TIM 4. Thromb Res 63: 651–659
Pulido JS, Lingua RW, Cristol S, Byrne S (1987) Protein C deficiency associated with vitreous hemorrhage in a neonate. Am J Ophthalmol 104: 272–276
Schapiro A and the International Factor Safety Study Group (1992) A study to determine the safety of virus inactivated factor concentrates in hemophiliacs naive to blood product administration. Proceedings of the XX International Congress of the World Federation of Hemophilia, Athens
Schwarz HP, Schramm W, Dreyfus M (1990) Monoclonal antibody purified protein C concentrate; initial clinical experience. In: Bruley DF, Drohan WN (eds) Protein C and related anticoagulants. Gulf Publishing, Houston, pp 83–89
Shen MC, Chen SH, Lin KS (1987) Two cases of purpura fulminans homozygous for Protein C deficiency in a chinese family. Thromb Haemost 58: 411
Tarras S, Gadia C, Meister L Roldan E, Gregorias JB (1988) Homozygous Protein C deficiency in a newborn: clinico-pathologic correlation. Arch Neurol 45: 214–216
Tuddenham EGD, Takase T, Thomas AE, Awidi AS, Madanat FF, Abu Hajir MM, Kernoff PB, Hoffbrand AV (1989) Homozygous protein C deficiency with delayed onset of symptoms at 7 to 10 months. Thromb Res 53: 475–484
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baliga, V., Thwaites, R., Tillyer, M.L. et al. Homozygous protein C deficiency—management with protein C concentrate. Eur J Pediatr 154, 534–538 (1995). https://doi.org/10.1007/BF02074829
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02074829